Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis Academic Article Article uri icon

Overview

MeSH Major

  • Epigenesis, Genetic
  • Inflammatory Bowel Diseases
  • Stress, Physiological

abstract

  • Results suggest that patients with symptoms of diabetic gastroparesis experience notable HRQOL impairment and that symptomatic relief with domperidone is accompanied by improvements in HRQOL that can be sustained over 4 weeks of treatment.

publication date

  • October 13, 1998

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.2337/diacare.21.10.1699

PubMed ID

  • 9773734

Additional Document Info

start page

  • 1699

end page

  • 706

volume

  • 21

number

  • 10